Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedGuide Requirements Need To Be Overhauled, Pharmacy Groups Tell FDA

Executive Summary

FDA's use of Medication Guides is being challenged by pharmacy groups just as the documents are taking on growing importance as a cornerstone of the agency's new safety powers

You may also be interested in...



FDA Poised To Overhaul Distribution Of Consumer Medical Information

FDA appears poised to begin an overhaul of the dissemination of consumer drug information

FDA Poised To Overhaul Distribution Of Consumer Medical Information

FDA appears poised to begin an overhaul of the dissemination of consumer drug information

The Downside Of REMS: An Over-Taxed Health Care System – FDA’s Jenkins

The increasing number of Risk Evaluation & Mitigation Strategies for drug and biotechnology products could cripple the current health care system - and force an overhaul of the way REMS are administered

Related Content

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel